![Page 1: Case 2:10-cv-00147-ABJ Document 27 Filed …i.bnet.com/blogs/fda-response-lannett.pdfCase 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 1 of 43](https://reader033.vdocuments.us/reader033/viewer/2022042804/5f519e8c2339ff48c31e2081/html5/thumbnails/1.jpg)
Case 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 1 of 43
![Page 2: Case 2:10-cv-00147-ABJ Document 27 Filed …i.bnet.com/blogs/fda-response-lannett.pdfCase 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 1 of 43](https://reader033.vdocuments.us/reader033/viewer/2022042804/5f519e8c2339ff48c31e2081/html5/thumbnails/2.jpg)
Case 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 2 of 43
![Page 3: Case 2:10-cv-00147-ABJ Document 27 Filed …i.bnet.com/blogs/fda-response-lannett.pdfCase 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 1 of 43](https://reader033.vdocuments.us/reader033/viewer/2022042804/5f519e8c2339ff48c31e2081/html5/thumbnails/3.jpg)
Case 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 3 of 43
![Page 4: Case 2:10-cv-00147-ABJ Document 27 Filed …i.bnet.com/blogs/fda-response-lannett.pdfCase 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 1 of 43](https://reader033.vdocuments.us/reader033/viewer/2022042804/5f519e8c2339ff48c31e2081/html5/thumbnails/4.jpg)
Case 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 4 of 43
![Page 5: Case 2:10-cv-00147-ABJ Document 27 Filed …i.bnet.com/blogs/fda-response-lannett.pdfCase 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 1 of 43](https://reader033.vdocuments.us/reader033/viewer/2022042804/5f519e8c2339ff48c31e2081/html5/thumbnails/5.jpg)
Case 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 5 of 43
![Page 6: Case 2:10-cv-00147-ABJ Document 27 Filed …i.bnet.com/blogs/fda-response-lannett.pdfCase 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 1 of 43](https://reader033.vdocuments.us/reader033/viewer/2022042804/5f519e8c2339ff48c31e2081/html5/thumbnails/6.jpg)
Case 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 6 of 43
![Page 7: Case 2:10-cv-00147-ABJ Document 27 Filed …i.bnet.com/blogs/fda-response-lannett.pdfCase 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 1 of 43](https://reader033.vdocuments.us/reader033/viewer/2022042804/5f519e8c2339ff48c31e2081/html5/thumbnails/7.jpg)
Case 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 7 of 43
![Page 8: Case 2:10-cv-00147-ABJ Document 27 Filed …i.bnet.com/blogs/fda-response-lannett.pdfCase 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 1 of 43](https://reader033.vdocuments.us/reader033/viewer/2022042804/5f519e8c2339ff48c31e2081/html5/thumbnails/8.jpg)
Case 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 8 of 43
![Page 9: Case 2:10-cv-00147-ABJ Document 27 Filed …i.bnet.com/blogs/fda-response-lannett.pdfCase 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 1 of 43](https://reader033.vdocuments.us/reader033/viewer/2022042804/5f519e8c2339ff48c31e2081/html5/thumbnails/9.jpg)
Case 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 9 of 43
![Page 10: Case 2:10-cv-00147-ABJ Document 27 Filed …i.bnet.com/blogs/fda-response-lannett.pdfCase 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 1 of 43](https://reader033.vdocuments.us/reader033/viewer/2022042804/5f519e8c2339ff48c31e2081/html5/thumbnails/10.jpg)
Case 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 10 of 43
![Page 11: Case 2:10-cv-00147-ABJ Document 27 Filed …i.bnet.com/blogs/fda-response-lannett.pdfCase 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 1 of 43](https://reader033.vdocuments.us/reader033/viewer/2022042804/5f519e8c2339ff48c31e2081/html5/thumbnails/11.jpg)
Case 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 11 of 43
![Page 12: Case 2:10-cv-00147-ABJ Document 27 Filed …i.bnet.com/blogs/fda-response-lannett.pdfCase 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 1 of 43](https://reader033.vdocuments.us/reader033/viewer/2022042804/5f519e8c2339ff48c31e2081/html5/thumbnails/12.jpg)
Case 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 12 of 43
![Page 13: Case 2:10-cv-00147-ABJ Document 27 Filed …i.bnet.com/blogs/fda-response-lannett.pdfCase 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 1 of 43](https://reader033.vdocuments.us/reader033/viewer/2022042804/5f519e8c2339ff48c31e2081/html5/thumbnails/13.jpg)
Case 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 13 of 43
![Page 14: Case 2:10-cv-00147-ABJ Document 27 Filed …i.bnet.com/blogs/fda-response-lannett.pdfCase 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 1 of 43](https://reader033.vdocuments.us/reader033/viewer/2022042804/5f519e8c2339ff48c31e2081/html5/thumbnails/14.jpg)
Case 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 14 of 43
![Page 15: Case 2:10-cv-00147-ABJ Document 27 Filed …i.bnet.com/blogs/fda-response-lannett.pdfCase 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 1 of 43](https://reader033.vdocuments.us/reader033/viewer/2022042804/5f519e8c2339ff48c31e2081/html5/thumbnails/15.jpg)
Case 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 15 of 43
![Page 16: Case 2:10-cv-00147-ABJ Document 27 Filed …i.bnet.com/blogs/fda-response-lannett.pdfCase 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 1 of 43](https://reader033.vdocuments.us/reader033/viewer/2022042804/5f519e8c2339ff48c31e2081/html5/thumbnails/16.jpg)
Case 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 16 of 43
![Page 17: Case 2:10-cv-00147-ABJ Document 27 Filed …i.bnet.com/blogs/fda-response-lannett.pdfCase 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 1 of 43](https://reader033.vdocuments.us/reader033/viewer/2022042804/5f519e8c2339ff48c31e2081/html5/thumbnails/17.jpg)
Case 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 17 of 43
![Page 18: Case 2:10-cv-00147-ABJ Document 27 Filed …i.bnet.com/blogs/fda-response-lannett.pdfCase 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 1 of 43](https://reader033.vdocuments.us/reader033/viewer/2022042804/5f519e8c2339ff48c31e2081/html5/thumbnails/18.jpg)
Case 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 18 of 43
![Page 19: Case 2:10-cv-00147-ABJ Document 27 Filed …i.bnet.com/blogs/fda-response-lannett.pdfCase 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 1 of 43](https://reader033.vdocuments.us/reader033/viewer/2022042804/5f519e8c2339ff48c31e2081/html5/thumbnails/19.jpg)
Case 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 19 of 43
![Page 20: Case 2:10-cv-00147-ABJ Document 27 Filed …i.bnet.com/blogs/fda-response-lannett.pdfCase 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 1 of 43](https://reader033.vdocuments.us/reader033/viewer/2022042804/5f519e8c2339ff48c31e2081/html5/thumbnails/20.jpg)
Case 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 20 of 43
![Page 21: Case 2:10-cv-00147-ABJ Document 27 Filed …i.bnet.com/blogs/fda-response-lannett.pdfCase 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 1 of 43](https://reader033.vdocuments.us/reader033/viewer/2022042804/5f519e8c2339ff48c31e2081/html5/thumbnails/21.jpg)
Case 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 21 of 43
![Page 22: Case 2:10-cv-00147-ABJ Document 27 Filed …i.bnet.com/blogs/fda-response-lannett.pdfCase 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 1 of 43](https://reader033.vdocuments.us/reader033/viewer/2022042804/5f519e8c2339ff48c31e2081/html5/thumbnails/22.jpg)
Case 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 22 of 43
![Page 23: Case 2:10-cv-00147-ABJ Document 27 Filed …i.bnet.com/blogs/fda-response-lannett.pdfCase 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 1 of 43](https://reader033.vdocuments.us/reader033/viewer/2022042804/5f519e8c2339ff48c31e2081/html5/thumbnails/23.jpg)
Case 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 23 of 43
![Page 24: Case 2:10-cv-00147-ABJ Document 27 Filed …i.bnet.com/blogs/fda-response-lannett.pdfCase 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 1 of 43](https://reader033.vdocuments.us/reader033/viewer/2022042804/5f519e8c2339ff48c31e2081/html5/thumbnails/24.jpg)
Case 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 24 of 43
![Page 25: Case 2:10-cv-00147-ABJ Document 27 Filed …i.bnet.com/blogs/fda-response-lannett.pdfCase 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 1 of 43](https://reader033.vdocuments.us/reader033/viewer/2022042804/5f519e8c2339ff48c31e2081/html5/thumbnails/25.jpg)
Case 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 25 of 43
![Page 26: Case 2:10-cv-00147-ABJ Document 27 Filed …i.bnet.com/blogs/fda-response-lannett.pdfCase 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 1 of 43](https://reader033.vdocuments.us/reader033/viewer/2022042804/5f519e8c2339ff48c31e2081/html5/thumbnails/26.jpg)
Case 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 26 of 43
![Page 27: Case 2:10-cv-00147-ABJ Document 27 Filed …i.bnet.com/blogs/fda-response-lannett.pdfCase 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 1 of 43](https://reader033.vdocuments.us/reader033/viewer/2022042804/5f519e8c2339ff48c31e2081/html5/thumbnails/27.jpg)
Case 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 27 of 43
![Page 28: Case 2:10-cv-00147-ABJ Document 27 Filed …i.bnet.com/blogs/fda-response-lannett.pdfCase 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 1 of 43](https://reader033.vdocuments.us/reader033/viewer/2022042804/5f519e8c2339ff48c31e2081/html5/thumbnails/28.jpg)
Case 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 28 of 43
![Page 29: Case 2:10-cv-00147-ABJ Document 27 Filed …i.bnet.com/blogs/fda-response-lannett.pdfCase 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 1 of 43](https://reader033.vdocuments.us/reader033/viewer/2022042804/5f519e8c2339ff48c31e2081/html5/thumbnails/29.jpg)
Case 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 29 of 43
![Page 30: Case 2:10-cv-00147-ABJ Document 27 Filed …i.bnet.com/blogs/fda-response-lannett.pdfCase 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 1 of 43](https://reader033.vdocuments.us/reader033/viewer/2022042804/5f519e8c2339ff48c31e2081/html5/thumbnails/30.jpg)
Case 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 30 of 43
![Page 31: Case 2:10-cv-00147-ABJ Document 27 Filed …i.bnet.com/blogs/fda-response-lannett.pdfCase 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 1 of 43](https://reader033.vdocuments.us/reader033/viewer/2022042804/5f519e8c2339ff48c31e2081/html5/thumbnails/31.jpg)
Case 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 31 of 43
![Page 32: Case 2:10-cv-00147-ABJ Document 27 Filed …i.bnet.com/blogs/fda-response-lannett.pdfCase 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 1 of 43](https://reader033.vdocuments.us/reader033/viewer/2022042804/5f519e8c2339ff48c31e2081/html5/thumbnails/32.jpg)
Case 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 32 of 43
![Page 33: Case 2:10-cv-00147-ABJ Document 27 Filed …i.bnet.com/blogs/fda-response-lannett.pdfCase 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 1 of 43](https://reader033.vdocuments.us/reader033/viewer/2022042804/5f519e8c2339ff48c31e2081/html5/thumbnails/33.jpg)
Case 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 33 of 43
![Page 34: Case 2:10-cv-00147-ABJ Document 27 Filed …i.bnet.com/blogs/fda-response-lannett.pdfCase 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 1 of 43](https://reader033.vdocuments.us/reader033/viewer/2022042804/5f519e8c2339ff48c31e2081/html5/thumbnails/34.jpg)
Case 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 34 of 43
![Page 35: Case 2:10-cv-00147-ABJ Document 27 Filed …i.bnet.com/blogs/fda-response-lannett.pdfCase 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 1 of 43](https://reader033.vdocuments.us/reader033/viewer/2022042804/5f519e8c2339ff48c31e2081/html5/thumbnails/35.jpg)
Case 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 35 of 43
![Page 36: Case 2:10-cv-00147-ABJ Document 27 Filed …i.bnet.com/blogs/fda-response-lannett.pdfCase 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 1 of 43](https://reader033.vdocuments.us/reader033/viewer/2022042804/5f519e8c2339ff48c31e2081/html5/thumbnails/36.jpg)
Case 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 36 of 43
![Page 37: Case 2:10-cv-00147-ABJ Document 27 Filed …i.bnet.com/blogs/fda-response-lannett.pdfCase 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 1 of 43](https://reader033.vdocuments.us/reader033/viewer/2022042804/5f519e8c2339ff48c31e2081/html5/thumbnails/37.jpg)
Case 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 37 of 43
![Page 38: Case 2:10-cv-00147-ABJ Document 27 Filed …i.bnet.com/blogs/fda-response-lannett.pdfCase 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 1 of 43](https://reader033.vdocuments.us/reader033/viewer/2022042804/5f519e8c2339ff48c31e2081/html5/thumbnails/38.jpg)
Case 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 38 of 43
![Page 39: Case 2:10-cv-00147-ABJ Document 27 Filed …i.bnet.com/blogs/fda-response-lannett.pdfCase 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 1 of 43](https://reader033.vdocuments.us/reader033/viewer/2022042804/5f519e8c2339ff48c31e2081/html5/thumbnails/39.jpg)
Case 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 39 of 43
![Page 40: Case 2:10-cv-00147-ABJ Document 27 Filed …i.bnet.com/blogs/fda-response-lannett.pdfCase 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 1 of 43](https://reader033.vdocuments.us/reader033/viewer/2022042804/5f519e8c2339ff48c31e2081/html5/thumbnails/40.jpg)
Case 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 40 of 43
![Page 41: Case 2:10-cv-00147-ABJ Document 27 Filed …i.bnet.com/blogs/fda-response-lannett.pdfCase 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 1 of 43](https://reader033.vdocuments.us/reader033/viewer/2022042804/5f519e8c2339ff48c31e2081/html5/thumbnails/41.jpg)
Case 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 41 of 43
![Page 42: Case 2:10-cv-00147-ABJ Document 27 Filed …i.bnet.com/blogs/fda-response-lannett.pdfCase 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 1 of 43](https://reader033.vdocuments.us/reader033/viewer/2022042804/5f519e8c2339ff48c31e2081/html5/thumbnails/42.jpg)
Case 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 42 of 43
![Page 43: Case 2:10-cv-00147-ABJ Document 27 Filed …i.bnet.com/blogs/fda-response-lannett.pdfCase 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 1 of 43](https://reader033.vdocuments.us/reader033/viewer/2022042804/5f519e8c2339ff48c31e2081/html5/thumbnails/43.jpg)
Case 2:10-cv-00147-ABJ Document 27 Filed 07/22/10 Page 43 of 43